Yuyu Pharma
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Yuyu Pharma makes prescription medicines and health-supplement products for human use, and supplies finished pharmaceuticals to hospitals and clinics across South Korea.
It also manufactures medicines on a contract basis for other domestic pharmaceutical companies and exports finished drug products to markets in Southeast Asia, Latin America, and beyond. Listed on KOSPI, South Korea's main stock exchange, the company operates through several subsidiaries covering health-supplement manufacturing, medical-device distribution, veterinary drug research, and pet-health products.
Summary is AI-generated and may contain errors · figures from DART filings
Its subsidiaries include US-based entities, YUYU VENTURES, YUYU BIO, and MERVYNS PETCARE, extending the group's footprint into veterinary drug research and pet-health products in the United States.
Yuyu Pharma in five facts
What does Yuyu Pharma do?
Yuyu Pharma makes prescription medicines and health-supplement products for human use, and supplies finished pharmaceuticals to hospitals and clinics across South Korea.
Where is Yuyu Pharma listed and in which sector?
Yuyu Pharma (Korean name: 유유제약) trades under KRX code 000220 on KOSPI, the main board of the Korea Exchange. It is classified in the Health Care sector, Pharmaceuticals.
How large is Yuyu Pharma?
Its market capitalisation was US$44.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Yuyu Pharma's latest annual revenue and operating profit?
For fiscal year 2025, Yuyu Pharma reported revenue of US$106.3M, operating profit of US$8.3M and net income of US$6.9M, per its annual report on DART (data retrieved from DART on 2026-09-05). Revenue was up 5.8% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-05
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.